NCT03815344 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- 1 hour post surgery
- Other-event reporting threshold
- 0%
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Standard | 0 / 42 | 0 / 42 | 0 / 42 |
| Standard-Vaginal Misoprostol | 0 / 32 | 0 / 32 | 0 / 32 |
Serious adverse events
Other reported adverse events
Complete source fields
- event Groups
- deaths Num Affected
- 0
- deaths Num At Risk
- 42
- description
- Use of laparoscopic injection of diluted vasopressin (20units in 100mL 0.9NS) prior to incision throughout the myomectomy. Standard-vaginal misoprostol: 20 units diluted in 100mL of Normal Saline injected laparoscopic needle and misoprostol 400 mcg
- id
- EG000
- other Num Affected
- 0
- other Num At Risk
- 42
- serious Num Affected
- 0
- serious Num At Risk
- 42
- title
- Standard
- deaths Num Affected
- 0
- deaths Num At Risk
- 32
- description
- Use of laparoscopic injection of diluted vasopressin (20units in 100mL 0.9NS) prior to incision throughout the myomectomy. 400mcg of misoprostol placed in the vagina at HUMI/foley placement . Standard: 20 units diluted in 100mL of Normal Saline injected laparoscopic needle Standard-vaginal misoprostol: 20 units diluted in 100mL of Normal Saline injected laparoscopic needle and misoprostol 400 mcg
- id
- EG001
- other Num Affected
- 0
- other Num At Risk
- 32
- serious Num Affected
- 0
- serious Num At Risk
- 32
- title
- Standard-Vaginal Misoprostol
- frequency Threshold
- 0
- time Frame
- 1 hour post surgery
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle